Infectious Disease Diagnostic Market was valued at US$ 36.1 Bn. in 2022. Infectious Disease Diagnostic Market size is estimated to grow at a CAGR of 4.6 % over the forecast period.Market Overview:
The report explores the Infectious Disease Diagnostic market’s segments (Techniques, Disease, and End-User). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). This market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2018 to 2022. The report investigates the Infectious Disease Diagnostic market’s drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Infectious Disease Diagnostic market’s contemporary competitive scenario.To know about the Research Methodology:-Request Free Sample Report
Infectious Disease Diagnostic Market Dynamics:
The global prevalence of infectious diseases: The occurrence of infectious diseases in developed and developing regions will positively influence the growth of the infectious disease diagnostics market. The diagnosis and management of such diseases are accountable for the increasing number of prescriptions for infectious disease diagnostic tests. These factors, along with the growing trend for preventive medicine, are expected to drive the demand for infectious disease diagnostics during the forecast period. The broad-scale population-based testing is required to improve prevention and control efforts for COVID-19. These tests are performed by infectious disease diagnostics; hence, they had a positive impact on this market. Additionally, the increase in government funding, rising healthcare costs, and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also intensify the overall growth of the market. Though, the lack of adequate reimbursement mechanisms in developed economies and some emerging economies hinders the market’s growth. The major and growing trend in the epidemiology market is the increasing adoption of technologically advanced visual diagnostic equipment in healthcare organizations in emerging economies is expected to generate profitable opportunities for the market. On the other hand, the rising health care costs in developed economies and a lack of awareness about infectious diseases have the potential to challenge the market’s growth. Growing opportunities in growing economies: Developing economies such as India, South Korea, Brazil, and Mexico are expected to offer potential growth opportunities for major players operating in the infectious disease diagnostics market. This can be attributed to the high disease prevalence, large patient population, improved healthcare infrastructure, increased disposable income, and growing medical tourism in these countries. In addition to the factors mentioned above, the Asia Pacific has emerged as an adaptive and business-friendly hub due to relatively less stringent regulations and data requirements. Unfavorable reimbursement scenario: The inadequate reimbursement is a major factor restraining the growth of the infectious disease diagnostics market. Most diagnostic companies face a major challenge in commercializing their tests is getting health insurers to pay for them. These are some of the factors that are leading through the forecast period. Infectious Disease Diagnostic Market Trends: The significant increase in the number of medical laboratories, for infectious disease diagnostic testing, anticipates the growth market’s growth Government of India, 2020, announced the launch of three state-of-the-art high throughput Indian Council of Medical Research labs in Kolkata, Mumbai, and Noida, to increase the COVID-19 testing capacity. Apart from COVID-19 tests, these labs are also used for other diagnostic tests for infectious diseases such as HIV, hepatitis, tuberculosis, and dengue. Also, a rise in awareness among individuals for early diagnosis and management of infectious diseases, and an increase in the number of information technology systems to develop advanced diagnostic devices are expected to provide remunerative opportunities for the expansion of the global infectious disease diagnostic market during the forecast period. Disease diagnostics are used for confirmation of the disease in form of a quick, precise test result. Being time-consuming, disease diagnostics are on the rise for the past few years. The infectious disease epidemics are exploding worldwide, raising an extensive demand for diagnostic tests. Moreover, the incidences of malaria, flu, AIDS, and other diseases are also rising, creating a robust demand for infectious disease diagnostics. With a majority of physicians adopting the evidence-based treatment method, infectious disease diagnostic kits are more likely to gain traction over the forecast period. Several government-funded programs all over the globe are increasingly providing free screening and tests to awareness, accurately diagnose diseases, and minimize the chances of infection. Such initiatives are anticipated to the market growth through the forecast period.Infectious Disease Diagnostic Market Segment Analysis:
By technique, the Infectious Disease Diagnostic market is segmented into lateral flow immunoassay, agglutination test, flow-through test/Immuno-concentration assay, molecular diagnostics, and others. The lateral flow immunoassay segment has dominated the largest market share accounting for xx% in 2022 and is expected to grow at a CAGR of 4.2% during the forecast period. The dominance is attributable to the faster diagnosis and availability of the test kits in decentralized settings. Additionally, increased product launch due to COVID-19 has also contributed to the growth of the segment. The molecular diagnostics segment is projected to register a higher CAGR by 2029 because of the increasing application of concepts such as RT-PCR, ELISA, etc., in infectious disease POC testing kits. Additionally, the rise in the number of FDA approvals is likely to boost the sales growth of the segment. Additionally, the flow-through test/immunoconcentration assay segment is expected to grow at a considerable CAGR during the forecast period because of the increasing number of market players engaged in introducing advanced kits based on the flow-through technique in the global market. Also, growing awareness about the application of agglutination tests for infectious disease diagnosis is expected to push forward the agglutination test segment during the forecast period. By diseases, the Infectious Disease Diagnostic market is segmented into HIV, hepatitis B virus, pneumonia/streptococcus associated infections, respiratory syncytial virus, influenza, Clostridium difficile infections (CDI), hepatitis C virus, MRSA, tuberculosis, and others. The clostridium difficile infections (CDI) segment has dominated the largest market share accounting for xx% in 2022 and is expected to grow at a CAGR of 4.2% during the forecast period.The increasing burden of under-diagnosis and the incidence rate of infectious diseases globally has led to the rapid adoption of POC testing kits leading to increased growth. This is because of the huge volume of sales of POC kits for CDI diagnosis. CDI is the most common infection found in patients who are in hospitals and critical care units. This has mainly contributed to the demand for CDI diagnosis kits. Influenza being the leading cause of acute respiratory infection has led to a higher adoption rate of these diagnostics products for timely disease management. Additionally, the growing R&D investments for advanced POC kits in developing nations are anticipated to boost the growth of the influenza segment through the forecast period.
Infectious Disease Diagnostic Market Regional Insights:
The North American region emerged as the dominant regional market share accounting for xx% and expand at a CAGR of 7.6% over the forecast period. This is because of the highly developed healthcare system, with the prevalence of infectious diseases, large numbers of major national clinical laboratories, and easy access to technologically advanced equipment. Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period owing to the higher demand for infectious diseases diagnostic kits because of the increasing patient pool and rising awareness among people. Asia Pacific region is expected to be the second dominant region in this market. This is because the governments of various countries in the Asia Pacific are increasingly registering a higher demand for infectious diseases diagnostic kits resulting in the largest market in this region, the MEA market will also witness a significantly growing market owing to the growth of governmental initiatives. The objective of the report is to present a comprehensive analysis of the global Infectious Disease Diagnostic Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear, futuristic view of the industry to the decision-makers. The reports also help in understanding the Infectious Disease Diagnostic Market dynamic and structure by analyzing the market segments and projecting the Infectious Disease Diagnostic Market size. Clear representation of competitive analysis of key players by Design, price, financial position, product portfolio, growth strategies, and regional presence in the Infectious Disease Diagnostic Market make the report investor’s guide.Infectious Disease Diagnostic Market Scope: Inquire before buying
Global Infectious Disease Diagnostic Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 36.1 Bn. Forecast Period 2023 to 2029 CAGR: 4.6% Market Size in 2029: US $ 49.46 Bn. Segments Covered: by Techniques lateral flow immunoassay agglutination test Flow-through test/Immuno-concentration assay Molecular diagnostics others by Disease HIV Hepatitis B Virus Pneumonia/Streptococcus-associated infection respiratory syncytial virus Influenza Clostridium difficile infection (CDI) Hepatitis C virus MRSA Tuberculosis others by End-User Hospitals Physician labs urgent care and retail clinic home and self-testing nursing home others Infectious Disease Diagnostic Market by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Infectious Disease Diagnostic Market Key Players:
1. F. Hoffmann-La Roche Ltd 2. Abbott Diagnostics 3. bioMérieux SA 4. Becton-Dickinson & Company 5. Siemens Healthineers 6. Thermo Fischer Scientific, Inc. 7. Bio-Rad Laboratories 8. Sysmex Corporation 9. Beckman Coulter 10.Danaher Corporation 11.Alere Inc. 12.Chembio Diagnostics Inc. 13.Cepheid Inc 14.DiaSorin 15.Meridian Bioscience 16.Trinity Biotech 17.Sekisui Diagnostics 18.Quidel Corporation 19.MedMira, Inc. 20.Calypte Biomedical Corporation 21.Johnson & Johnson Services Inc. 22.Hologic, Inc. 23.Qiagen N.V. 24.Sofina s.a. 25.Ingersoll-Rand plc. Frequently Asked Questions: 1] What segments are covered in the Infectious Disease Diagnostic Market report? Ans. The segments covered in the Infectious Disease Diagnostic Market report are based on Techniques, Disease, and End-User. 2] Which region is expected to hold the highest share in the Infectious Disease Diagnostic Market? Ans. The North American region is expected to hold the highest share in the Infectious Disease Diagnostic Market. 3] What is the market size of the Infectious Disease Diagnostic Market by 2029? Ans. The market size of the Infectious Disease Diagnostic Market by 2029 is US$ 49.46 Bn. 4] What is the forecast period for the Infectious Disease Diagnostic Market? Ans. The Forecast period for the Infectious Disease Diagnostic Market is 2023-2029. 5] What was the market size of the Infectious Disease Diagnostic Market in 2022? Ans. The market size of the Infectious Disease Diagnostic Market in 2022 was US$ 36.1 Bn.
1. Infectious Disease Diagnostic Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Infectious Disease Diagnostic Market: Dynamics 2.1. Infectious Disease Diagnostic Market Trends by Region 2.1.1. North America Infectious Disease Diagnostic Market Trends 2.1.2. Europe Infectious Disease Diagnostic Market Trends 2.1.3. Asia Pacific Infectious Disease Diagnostic Market Trends 2.1.4. Middle East and Africa Infectious Disease Diagnostic Market Trends 2.1.5. South America Infectious Disease Diagnostic Market Trends 2.2. Infectious Disease Diagnostic Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Infectious Disease Diagnostic Market Drivers 2.2.1.2. North America Infectious Disease Diagnostic Market Restraints 2.2.1.3. North America Infectious Disease Diagnostic Market Opportunities 2.2.1.4. North America Infectious Disease Diagnostic Market Challenges 2.2.2. Europe 2.2.2.1. Europe Infectious Disease Diagnostic Market Drivers 2.2.2.2. Europe Infectious Disease Diagnostic Market Restraints 2.2.2.3. Europe Infectious Disease Diagnostic Market Opportunities 2.2.2.4. Europe Infectious Disease Diagnostic Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Infectious Disease Diagnostic Market Drivers 2.2.3.2. Asia Pacific Infectious Disease Diagnostic Market Restraints 2.2.3.3. Asia Pacific Infectious Disease Diagnostic Market Opportunities 2.2.3.4. Asia Pacific Infectious Disease Diagnostic Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Infectious Disease Diagnostic Market Drivers 2.2.4.2. Middle East and Africa Infectious Disease Diagnostic Market Restraints 2.2.4.3. Middle East and Africa Infectious Disease Diagnostic Market Opportunities 2.2.4.4. Middle East and Africa Infectious Disease Diagnostic Market Challenges 2.2.5. South America 2.2.5.1. South America Infectious Disease Diagnostic Market Drivers 2.2.5.2. South America Infectious Disease Diagnostic Market Restraints 2.2.5.3. South America Infectious Disease Diagnostic Market Opportunities 2.2.5.4. South America Infectious Disease Diagnostic Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Infectious Disease Diagnostic Industry 2.8. Analysis of Government Schemes and Initiatives For Infectious Disease Diagnostic Industry 2.9. Infectious Disease Diagnostic Market Trade Analysis 2.10. The Global Pandemic Impact on Infectious Disease Diagnostic Market 3. Infectious Disease Diagnostic Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 3.1.1. lateral flow immunoassay 3.1.2. agglutination test 3.1.3. Flow-through test/Immuno-concentration assay 3.1.4. Molecular diagnostics 3.1.5. others 3.2. Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 3.2.1. HIV 3.2.2. Hepatitis B Virus 3.2.3. Pneumonia/Streptococcus-associated infection 3.2.4. respiratory syncytial virus 3.2.5. Influenza 3.2.6. Clostridium difficile infection (CDI) 3.2.7. Hepatitis C virus 3.2.8. MRSA 3.2.9. Tuberculosis 3.2.10. others 3.3. Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 3.3.1. Hospitals 3.3.2. Physician labs 3.3.3. urgent care and retail clinic 3.3.4. home and self-testing 3.3.5. nursing home 3.3.6. others 3.4. Infectious Disease Diagnostic Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Infectious Disease Diagnostic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 4.1.1. lateral flow immunoassay 4.1.2. agglutination test 4.1.3. Flow-through test/Immuno-concentration assay 4.1.4. Molecular diagnostics 4.1.5. others 4.2. North America Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 4.2.1. HIV 4.2.2. Hepatitis B Virus 4.2.3. Pneumonia/Streptococcus-associated infection 4.2.4. respiratory syncytial virus 4.2.5. Influenza 4.2.6. Clostridium difficile infection (CDI) 4.2.7. Hepatitis C virus 4.2.8. MRSA 4.2.9. Tuberculosis 4.2.10. others 4.3. North America Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 4.3.1. Hospitals 4.3.2. Physician labs 4.3.3. urgent care and retail clinic 4.3.4. home and self-testing 4.3.5. nursing home 4.3.6. others 4.4. North America Infectious Disease Diagnostic Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 4.4.1.1.1. lateral flow immunoassay 4.4.1.1.2. agglutination test 4.4.1.1.3. Flow-through test/Immuno-concentration assay 4.4.1.1.4. Molecular diagnostics 4.4.1.1.5. others 4.4.1.2. United States Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 4.4.1.2.1. HIV 4.4.1.2.2. Hepatitis B Virus 4.4.1.2.3. Pneumonia/Streptococcus-associated infection 4.4.1.2.4. respiratory syncytial virus 4.4.1.2.5. Influenza 4.4.1.2.6. Clostridium difficile infection (CDI) 4.4.1.2.7. Hepatitis C virus 4.4.1.2.8. MRSA 4.4.1.2.9. Tuberculosis 4.4.1.2.10. others 4.4.1.3. United States Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 4.4.1.3.1. Hospitals 4.4.1.3.2. Physician labs 4.4.1.3.3. urgent care and retail clinic 4.4.1.3.4. home and self-testing 4.4.1.3.5. nursing home 4.4.1.3.6. others 4.4.2. Canada 4.4.2.1. Canada Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 4.4.2.1.1. lateral flow immunoassay 4.4.2.1.2. agglutination test 4.4.2.1.3. Flow-through test/Immuno-concentration assay 4.4.2.1.4. Molecular diagnostics 4.4.2.1.5. others 4.4.2.2. Canada Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 4.4.2.2.1. HIV 4.4.2.2.2. Hepatitis B Virus 4.4.2.2.3. Pneumonia/Streptococcus-associated infection 4.4.2.2.4. respiratory syncytial virus 4.4.2.2.5. Influenza 4.4.2.2.6. Clostridium difficile infection (CDI) 4.4.2.2.7. Hepatitis C virus 4.4.2.2.8. MRSA 4.4.2.2.9. Tuberculosis 4.4.2.2.10. others 4.4.2.3. Canada Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 4.4.2.3.1. Hospitals 4.4.2.3.2. Physician labs 4.4.2.3.3. urgent care and retail clinic 4.4.2.3.4. home and self-testing 4.4.2.3.5. nursing home 4.4.2.3.6. others 4.4.3. Mexico 4.4.3.1. Mexico Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 4.4.3.1.1. lateral flow immunoassay 4.4.3.1.2. agglutination test 4.4.3.1.3. Flow-through test/Immuno-concentration assay 4.4.3.1.4. Molecular diagnostics 4.4.3.1.5. others 4.4.3.2. Mexico Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 4.4.3.2.1. HIV 4.4.3.2.2. Hepatitis B Virus 4.4.3.2.3. Pneumonia/Streptococcus-associated infection 4.4.3.2.4. respiratory syncytial virus 4.4.3.2.5. Influenza 4.4.3.2.6. Clostridium difficile infection (CDI) 4.4.3.2.7. Hepatitis C virus 4.4.3.2.8. MRSA 4.4.3.2.9. Tuberculosis 4.4.3.2.10. others 4.4.3.3. Mexico Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 4.4.3.3.1. Hospitals 4.4.3.3.2. Physician labs 4.4.3.3.3. urgent care and retail clinic 4.4.3.3.4. home and self-testing 4.4.3.3.5. nursing home 4.4.3.3.6. others 5. Europe Infectious Disease Diagnostic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.2. Europe Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.3. Europe Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4. Europe Infectious Disease Diagnostic Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.1.2. United Kingdom Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.1.3. United Kingdom Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.2. France 5.4.2.1. France Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.2.2. France Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.2.3. France Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.3. Germany 5.4.3.1. Germany Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.3.2. Germany Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.3.3. Germany Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.4.2. Italy Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.4.3. Italy Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.5. Spain 5.4.5.1. Spain Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.5.2. Spain Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.5.3. Spain Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.6.2. Sweden Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.6.3. Sweden Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.7.2. Austria Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.7.3. Austria Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 5.4.8.2. Rest of Europe Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 5.4.8.3. Rest of Europe Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6. Asia Pacific Infectious Disease Diagnostic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.2. Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.3. Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4. Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.1.2. China Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.1.3. China Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.2.2. S Korea Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.2.3. S Korea Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.3.2. Japan Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.3.3. Japan Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.4. India 6.4.4.1. India Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.4.2. India Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.4.3. India Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.5.2. Australia Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.5.3. Australia Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.6.2. Indonesia Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.6.3. Indonesia Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.7.2. Malaysia Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.7.3. Malaysia Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.8.2. Vietnam Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.8.3. Vietnam Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.9.2. Taiwan Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.9.3. Taiwan Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 6.4.10.2. Rest of Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 6.4.10.3. Rest of Asia Pacific Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 7. Middle East and Africa Infectious Disease Diagnostic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 7.2. Middle East and Africa Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 7.3. Middle East and Africa Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 7.4. Middle East and Africa Infectious Disease Diagnostic Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 7.4.1.2. South Africa Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 7.4.1.3. South Africa Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 7.4.2.2. GCC Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 7.4.2.3. GCC Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 7.4.3.2. Nigeria Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 7.4.3.3. Nigeria Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 7.4.4.2. Rest of ME&A Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 7.4.4.3. Rest of ME&A Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 8. South America Infectious Disease Diagnostic Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 8.2. South America Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 8.3. South America Infectious Disease Diagnostic Market Size and Forecast, by End-User(2022-2029) 8.4. South America Infectious Disease Diagnostic Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 8.4.1.2. Brazil Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 8.4.1.3. Brazil Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 8.4.2.2. Argentina Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 8.4.2.3. Argentina Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Infectious Disease Diagnostic Market Size and Forecast, by Techniques (2022-2029) 8.4.3.2. Rest Of South America Infectious Disease Diagnostic Market Size and Forecast, by Disease (2022-2029) 8.4.3.3. Rest Of South America Infectious Disease Diagnostic Market Size and Forecast, by End-User (2022-2029) 9. Global Infectious Disease Diagnostic Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Infectious Disease Diagnostic Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. F. Hoffmann-La Roche Ltd 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Abbott Diagnostics 10.3. bioMérieux SA 10.4. Becton-Dickinson & Company 10.5. Siemens Healthineers 10.6. Thermo Fischer Scientific, Inc. 10.7. Bio-Rad Laboratories 10.8. Sysmex Corporation 10.9. Beckman Coulter 10.10. Danaher Corporation 10.11. Alere Inc. 10.12. Chembio Diagnostics Inc. 10.13. Cepheid Inc 10.14. DiaSorin 10.15. Meridian Bioscience 10.16. Trinity Biotech 10.17. Sekisui Diagnostics 10.18. Quidel Corporation 10.19. MedMira, Inc. 10.20. Calypte Biomedical Corporation 10.21. Johnson & Johnson Services Inc. 10.22. Hologic, Inc. 10.23. Qiagen N.V. 10.24. Sofina s.a. 10.25. Ingersoll-Rand plc 11. Key Findings 12. Industry Recommendations 13. Infectious Disease Diagnostic Market: Research Methodology 14. Terms and Glossary